Recent advances in the treatment strategy for AAV improved outcomes with intensive GC tapering
ConclusionRecent developments in AAV treatment have allowed efficient remission and prevention of relapses, which in turn enabled extensive GC tapering causing fewer sequelae. (Source: International Journal of Rheumatic Diseases)
Source: International Journal of Rheumatic Diseases - December 22, 2023 Category: Rheumatology Authors: Nobuyuki Ono, Tatsuya Kai, Yukiko Takeyama, Yasushi Inoue, Naoyasu Ueda, Shuji Nagano, Shunichiro Ohta, Hisako Inoue, Takuya Sawabe, Yutaka Chifu, Seiji Yoshizawa, Kensuke Oryoji, Yasutaka Kimoto, Katsuhisa Miyake, Masahiro Ayano, Hiroki Mi Tags: ORIGINAL ARTICLE Source Type: research

GOUT ‐36 prediction rule is sensitive in predicting gout flare during COVID‐19 hospitalization
(Source: International Journal of Rheumatic Diseases)
Source: International Journal of Rheumatic Diseases - December 22, 2023 Category: Rheumatology Authors: Ariya Mongkolporn, Panchalee Satpanich, Rebecca Grainger, Kanon Jatuworapruk Tags: LETTER TO THE EDITOR Source Type: research

Rheumatoid arthritis knowledge gap and intervention in Nigeria study
ConclusionThis study highlights the importance of interventions in closing the knowledge gap about RA diagnosis and management. We recommend the implementation of a comprehensive approach to rheumatology education and services by policymakers. (Source: International Journal of Rheumatic Diseases)
Source: International Journal of Rheumatic Diseases - December 19, 2023 Category: Rheumatology Authors: Olaosebikan B. Hakeem, Yerima Abubakar, Uhunmwangho Courage, Odunlami Gbenga Joshua, Shodipo Olujimi, Umar Abdulaziz, Ima ‐Edomwonyi Uyi, Osaze Ojo, Olufemi Adelowo, Oguntona A. Olusegun, Henry Nwankwo, Dedeke Ibukunoluwa, Daiyabu Ibrahim, Tags: ORIGINAL ARTICLE Source Type: research

Phosphorylated vimentin at Ser72 is associated with epithelial –mesenchymal transition in lupus nephritis
ConclusionsVimentin phosphorylated on Ser72 is important for renal epithelial cell migration, which would enhance the progression of vimentin-induced epithelial –mesenchymal transition during LN development. (Source: International Journal of Rheumatic Diseases)
Source: International Journal of Rheumatic Diseases - December 11, 2023 Category: Rheumatology Authors: Daji Wang, Fan Zhang, Jing He, Chuyi Li, Xingjiao Liu, Meng Zhang, Haihui Huang, Zuying Xiong, Hongxia Duan, Xiaoyan Huang, Meiying Wang Tags: ORIGINAL ARTICLE Source Type: research

Antirheumatic drugs and the risk of nonalcoholic fatty liver disease in patients with rheumatoid arthritis: A nationwide, population ‐based cohort study
ConclusionThis study reveals that NSAID use and prednisolone equivalent dose>5  mg/day were associated with an increased risk of NAFLD in patients with RA, while the use of HCQ and prednisolone equivalent dose ≤5 mg/day decreased the risk of NAFLD. (Source: International Journal of Rheumatic Diseases)
Source: International Journal of Rheumatic Diseases - December 11, 2023 Category: Rheumatology Authors: Chia ‐Chu Meng, Der‐Yuan Chen, Yi‐Hsing Chen, Wen‐Nan Huang, Hsin‐Hua Chen Tags: ORIGINAL ARTICLE Source Type: research

Case report: Successful treatment with canakinumab of a patient with active ileitis associated with familial Mediterranean fever
(Source: International Journal of Rheumatic Diseases)
Source: International Journal of Rheumatic Diseases - December 10, 2023 Category: Rheumatology Authors: Dai Kishida, Ryosuke Hara, Takanori Ichikawa, Mai Iwaya, Yasuhiro Shimojima, Yoshiki Sekijima Tags: LETTER TO THE EDITOR Source Type: research

Aggressive multi ‐combination therapy for anti‐MDA5 antibody‐positive dermatomyositis‐rapidly progressive interstitial lung disease
ConclusionThis aggressive multi-combination therapy may improve the survival outcome of patients with anti-MDA5 antibody-positive DM-RPILD. However, careful management of complications, such as opportunistic infections and leukopenia, is essential. Future refinement through longitudinal investigations tracking the long-term efficacy, safety, and cost-effectiveness of this treatment strategy is needed. (Source: International Journal of Rheumatic Diseases)
Source: International Journal of Rheumatic Diseases - December 9, 2023 Category: Rheumatology Authors: Kenichiro Hata, Takuya Kotani, Shogo Matsuda, Youhei Fujiki, Takayasu Suzuka, Takao Kiboshi, Yumiko Wada, Hideyuki Shiba, Takeshi Shoda, Maki Kagitani, Tohru Takeuchi Tags: ORIGINAL ARTICLE Source Type: research

Comorbidities in idiopathic inflammatory myopathies: Data from the MyoCite cohort
(Source: International Journal of Rheumatic Diseases)
Source: International Journal of Rheumatic Diseases - December 8, 2023 Category: Rheumatology Authors: Edoardo Conticini, Tayyeba Khursheed, Anamika Kumari Anuja, Vikas Agarwal, Latika Gupta Tags: LETTER TO THE EDITOR Source Type: research

Extensive calcific coronary artery aneurysm with stenosis in a child with Kawasaki disease: Follow ‐up by CT coronary angiography
(Source: International Journal of Rheumatic Diseases)
Source: International Journal of Rheumatic Diseases - December 8, 2023 Category: Rheumatology Authors: Rakesh Kumar Pilania, Manphool Singhal, Suprit Basu, Arun Sharma, Surjit Singh Tags: CLINICAL IMAGE Source Type: research

Screening, prophylaxis, and challenges: Tumor necrosis factor inhibitors and latent tuberculosis infection nexus in rheumatology
(Source: International Journal of Rheumatic Diseases)
Source: International Journal of Rheumatic Diseases - December 8, 2023 Category: Rheumatology Authors: Kaisheng Su, Ximeng Li, Zhenyu Jiang, Yifang Mei Tags: EDITORIAL Source Type: research

MEFV gene test —Who's ordering them and why? A retrospective study from an Australian referrals center
(Source: International Journal of Rheumatic Diseases)
Source: International Journal of Rheumatic Diseases - December 8, 2023 Category: Rheumatology Authors: Sam Shan, Mueed Mian Tags: LETTER TO THE EDITOR Source Type: research

Factors associated with mental illness in patients with rheumatoid arthritis initiating b/ts DMARDs: A population ‐based study
ConclusionThis population-based study investigated the incidence and factors associated with mental illness among patients with RA receiving b/tsDMARDs. Our findings highlight the need for vigilance with respect to the possibility of mental illness in patients with RA. (Source: International Journal of Rheumatic Diseases)
Source: International Journal of Rheumatic Diseases - December 8, 2023 Category: Rheumatology Authors: Hsin ‐Hua Chen, Peng‐Yen Wu, Ching‐Heng Lin, Chieh‐Liang Wu, Wen‐Cheng Chao Tags: ORIGINAL ARTICLE Source Type: research

Correspondence on “hearing loss in ankylosing spondylitis”
(Source: International Journal of Rheumatic Diseases)
Source: International Journal of Rheumatic Diseases - December 7, 2023 Category: Rheumatology Authors: Hsin ‐Tien Wu, Renin Chang Tags: LETTER TO THE EDITOR Source Type: research

Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality rates
ConclusionComorbidities and control of disease activity are critical in the development of CKD in RA patients receiving b/ts-DMARDs. While there was no significant difference in mortality rate between CKD and non-CKD patients, the overall mortality rate increased after the COVID-19 pandemic duration in both groups. (Source: International Journal of Rheumatic Diseases)
Source: International Journal of Rheumatic Diseases - December 7, 2023 Category: Rheumatology Authors: G üllü Sandal Uzun, Arzu Taghiyeva, İbrahim Y. Çakır, Kenan Moral, Gözde Kübra Yardımcı, Ertuğrul Ç. Bölek, Bayram Farisoğulları, Emine Duran, Gizem Ayan, Zehra Özsoy, Mustafa Ekici, Erdinç Unaldı, Şerife A. Germe, Büşra Tags: ORIGINAL ARTICLE Source Type: research

Issue Information
(Source: International Journal of Rheumatic Diseases)
Source: International Journal of Rheumatic Diseases - December 2, 2023 Category: Rheumatology Tags: ISSUE INFORMATION Source Type: research